Arcturus Therapeutics Holdings Inc logo

Arcturus Therapeutics Holdings Inc

$ 14.82 +0.84 (+6.01%) 10:08 PM EST
P/E:
At Loss
P/B:
2.29
Market Cap:
$ 393.86M
Enterprise V:
$ 208.77M
Volume:
357.99K
Avg Vol (2M):
459.10K
Volume:
357.99K
Market Cap $:
393.86M
PE Ratio:
At Loss
Avg Vol (2-Month):
459.10K
Enterprise Value $:
208.77M
PB Ratio:
2.29
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Name Current Vs Industry Vs History
Cash-To-Debt 2.88
Equity-to-Asset 0.51
Debt-to-Equity 0.58
Debt-to-EBITDA -0.61
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.09
Distress
Grey
Safe
Beneish M-Score 0.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.51
9-Day RSI 50.41
14-Day RSI 48.11
6-1 Month Momentum % -47.92
12-1 Month Momentum % -70.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.14
Quick Ratio 3.14
Cash Ratio 3.06
Days Sales Outstanding 24.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35

Financials (Next Earnings Date:2022-11-08 Est.)

ARCT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARCT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 40.568
EPS (TTM) ($) -6.28
Beta 2.63
Volatility % 49.91
14-Day RSI 48.11
14-Day ATR ($) 1.308952
20-Day SMA ($) 14.837
12-1 Month Momentum % -70.62
52-Week Range ($) 11.7 - 48.75
Shares Outstanding (Mil) 26.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arcturus Therapeutics Holdings Inc Filings

Document Form Filing Date
No Filing Data

Arcturus Therapeutics Holdings Inc Analysis

Share your research

Headlines

See More
No news.